chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects reported; improperly stored doses of PROQUAD was administered to the patient; This spontaneous report has been received from an office manager (medical assistant) regarding to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medication, drug allergies or reaction were not reported.     On 19-MAY-2019, the patient was vaccinated with an improperly store dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (recombinant human albumin, rHA) (lot # R008206 and expiration date 19- SEP-2019) (dose and anatomical location of vaccination were not reported) mixed with a properly stored sterile diluent (DILUENT MRK) for prophylaxis. The administered dose of the vaccine experienced a temperature excursion to 9°C to 25 °C (20.5 °C) for a time frame of 22 hours and 30 minutes. From -9°C to 8°C for 1 hour 15 minutes and -14 °C to -10°C for 1 hour 30 minutes. There was no previous temperature excursion.The call was because of a "data logger".. There were no adverse effects reported.   This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1905USA010085: US-009507513-1905USA010082: US-009507513-1905USA010081: US-009507513-1905USA010080: US-009507513-1905USA010084: US-009507513-1905USA010092: US-009507513-1905USA010083:
This spontaneous report was received from a pharmacist via company representative refers to a 20 year old patient with unknown gender. Patient medical history and historical conditions were not reported. On an unknown date, the patient inadvertently received ZOSTAVAX (dose, lot # were not reported) instead of VARIVAX (Merck) and no adverse effect reported. That was related to a staff error. Concomitant therapy was not reported. No PQC was involved. Outcome of events was unknown. The reporter considered patient inadvertently received ZOSTAVAX instead of VARIVAX (Merck) and no adverse effect to be not related to ZOSTAVAX. This case was linked to MARRS # 1409USA006963 (same patient link). Additional information has been requested.
Moderna COVID-19 Vaccine EUA: Higher-than-authorized dose volume administered Patient received 0.5 ml dose of Moderna Covid Vaccine on 1/11/21 and a 1 ml dose of Moderna Covid vaccine on 6/1/21.
Feeling sick after the Modena vaccine; Stomachache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN UPPER (Stomachache) and MALAISE (Feeling sick after the Modena vaccine) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ABDOMINAL PAIN UPPER (Stomachache). On an unknown date, the patient experienced MALAISE (Feeling sick after the Modena vaccine). At the time of the report, ABDOMINAL PAIN UPPER (Stomachache) and MALAISE (Feeling sick after the Modena vaccine) outcome was unknown.            Concomitant product use was not provided by the reporter.  After 2-3 weeks of vaccination patient experienced stomachache, patient thought this was indigestion or pancreatitis. Patient contacted doctor online. Patient's condition aggravated after second dose and died on 05-Jun-2021.  No treatment was provided.  Action taken with mRNA-1273 in response to the events was not Applicable.    This case was linked to MOD-2021-211616 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow up information received on  07-May-2021 had a new event feeling sick after the Modena vaccine was added to the case.
she tensed up, head fell forward, eyes rolled then slumped back in chair about 5 minutes after receiving first dose of pfizer . stayed fully awake
Three weeks after getting shot, woke up with entire RIGHT (not injection arm) arm and shoulder in severe pain... that I recognized from having had it previously as post herpetic neuropathy.  I've had Shingles in the past, and have had both levels of Shingles vaccinations... the latest being the Shingrix vaccine about three years previously.  I have previously had the post herpetic neuropathy on six or seven different occasions, so I know it well.  I have not had it since getting the Shingrix vaccine three years ago, however.  Normally an attack would last between two and three weeks.  This attack lasted eight months.  My wife experienced the same phenomena, though her attack only lasted about a week.  My doctor told me several of her patients have had that reaction to the vaccine.
2nd vaccine in Friday morning.  At night and Saturday whole day staff having bodyache, headache, fever 100.5.  Sunday morning a lot better but found a lump in armpit.  This morning feeling better no symptom except the lump in armpit which is almost gone but feeling another lump in neck.  All lumps happen to be in left side. Got shot on left arm. Called to advise nurse and told to call PCP, which he hasn't called yet.
July 24, 2021:  Tested positive for Coronavirus (COVID-19) after one day of symptoms at walk-in clinic.  Symptoms were sore throat, congestion, cough, low grade fever.
MISSED TO TAKE LAST TWO DOSES OF VIVOTIF ON TIME; This spontaneous case (PVX2019-1562) report was received from a pharmacist on 17-Jun-2019. It describes an adult female consumer who "missed to take last two doses of Vivotif on time". The consumer was receiving oral Vivotif (one capsule every other day) for typhoid prophylaxis.  Case report: The consumer took the first two doses of Vivotif on 10-Jun-2019 and 12-Jun-2019, respectively, but missed to take her last two doses.  Action taken with Vivotif was not applicable   The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "missed to take last two doses of Vivotif on time" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take last two doses of Vivotif on time" was considered as not applicable.
Mild clear nasal drainage, slight cough, temp 100.7  2/20/07 Received autopsy report which reveals COD as complications of pneumonitis.
Experience slight chest tightness/pain and reduced cardiovascular performance for approximately four weeks after second injection. Left untreated and resolved. // Experienced anal thrombosis approximately one month after second injection. Treated with anal suppositories and topical ointment. Resolved after three weeks. // Experienced eye infection (possible stye) approximately two months after second injection. Treated with antibiotics on two separate occasions after first treatment ineffective. // Experienced auto-immune disorder symptoms approximately four months after second injection. Symptoms include dry mouth, oral ulcers, bleeding gums, tooth sensitivity, gum erosion, white web-like appearance in oral cavity (similar to oral lichen planus). Treated with Prednisone on two occasions. Symptoms reduced but not resolved. Ongoing issue at time of VAERS submission.
Also had PPD skin test with vaccines given at 10:30am. Returned to school. At 1PM noted roof of mouth itching. At 1:30PM noted head, face, back, sides all itching, and 2 hives on chin. Was given Benedryl 50mg oral, at her school.  Drove home, fell asleep, awoke 1 hour later, still itchy.  Went to urgent care for treatment. Not admitted. Prescribed prednisone taper pack for 5 days.  Denies ever having resp. difficulty or rash - just 2 hives.
Mild body aches and chills consistent with a cold/virus.  Right arm sore at injection site
About 2 minutes after vaccine, my throat started feeling tight and itchy and so I flagged down one of the nurses and they took me behind this curtain and went over my symptoms. They gave me Benadryl and after my tongue and throat was swelling, they hit me with that and kept me for about an hour for observation. I was able to breathe the whole time, it was just a strong allergic reaction and not anaphylactic. They observed me for 45 minutes and I went home and slept through the night and felt achy and kind of sick. I would say the achiness lasted about 24 hours.
pt devel a fever of 101 & grunting p/vax;pt hosp;no further details were known @ the time of this report;this is 1 of 3 pt from this site to have adverse events following receipt of vax;
Passed out with sudden stomach ache, followed by extreme vomiting and diarrhea. Taken by ambulance to Hospital.
feels like he has the flu; temperature 101.8F; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like he has the flu) and PYREXIA (temperature 101.8F) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037V20A) for COVID-19 vaccination.     Concurrent medical conditions included Colitis.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (feels like he has the flu) and PYREXIA (temperature 101.8F). At the time of the report, INFLUENZA LIKE ILLNESS (feels like he has the flu) and PYREXIA (temperature 101.8F) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has been drinking water and Gatorade as treatment medication.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a medical assistant regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 11-NOV-2015 the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # L018501, expiry date-22-JUN-2017) (dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
Lost partial vision in her left eye; Tingling on the injection site; Swelling of the face; Blurred vision; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BLINDNESS UNILATERAL (Lost partial vision in her left eye) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concurrent medical conditions included Allergy.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced PARAESTHESIA (Tingling on the injection site), SWELLING FACE (Swelling of the face) and VISION BLURRED (Blurred vision). On an unknown date, the patient experienced BLINDNESS UNILATERAL (Lost partial vision in her left eye) (seriousness criterion medically significant). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Allergic reaction, at an unspecified dose and frequency. At the time of the report, BLINDNESS UNILATERAL (Lost partial vision in her left eye) had not resolved and PARAESTHESIA (Tingling on the injection site), SWELLING FACE (Swelling of the face) and VISION BLURRED (Blurred vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Patient is immunocompromised. Based on the current available information which shows a strong temporal association between the use of mRNA-1273 and the onset of the reported events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up received on 31-MAY-2021: New AEs were updated(Blurred vision,partial vision lost); Sender's Comments: Based on the current available information which shows a strong temporal association between the use of mRNA-1273 and the onset of the reported events, a causal relationship cannot be excluded.
Expired vaccine was administered on 05-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered on 05-Apr-2022) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered on 05-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine was administered on 05-Apr-2022) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment medications was reported.  Reporter mentioned that there was incident because of miscommunication as a coworker told that there were some lot number whose expirations dates have been extended.  Patient received second booster dose.
On 2/17/2021, I received my first dose of the Moderna vaccine. On 2/18/2021, I began having heart palpitations. On 2/19/2021, I had a headache, sore throat, severe fatigue, and lightheadedness, all of which were likely side effects of the vaccine. On 2/24/2021, I felt a pressure in my chest. On 2/25/2021, I experienced both heart palpitations and a feeling of pressure in the chest. I went to the ER. I was kept there for 5 hours and underwent heart monitoring, blood work, and an EKG. No significant abnormalities were found, and I was sent home. As of 2/28/2021, I was still experiencing palpitations and chest pressure. I saw a cardiologist, Dr., on 3/10/2021. I no longer remember the details of the visit.
Patient was given vaccs/was told to stay seated for a little while afterwards/started not feeling well-got up and passed out hitting back of head on floor-went to E.R. and diagnosed with a concussion.
Muscle spasms, facial nerve tingling, burning sensation on face and scalp, rapid heart rate
HEART FAILURE; This spontaneous report received from a consumer via a company representative via social media concerned a 18 year old male of an unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from heart failure. It was unspecified if an autopsy was performed. The reporter stated that  "No, you do not have the data. Because injuries are not being reported into VAERS. I had 1 coworker whose lips and tongue went numb after his vaccine, and he nearly died. 2 others had severe tinnitus. One had hands so painful he sat there rubbing them nearly crying. Another had he and his wife both experiencing numb hands with loss of grip. Another coworker's wife has myocarditis. My supervisor's daughter had her 18 year old best friend die of heart failure after his vaccine. These adverse events are not rare, look in every comment section about Covid vaccines. And do not give me that "anecdotal" stuff. Big pharma can not hide behind that lie forever ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). This case, from the same reporter is linked to 20221243340, 20221243356, 20221243261, 20221243606, 20221245881 and 20221245969.; Sender's Comments: V0: 20221245816- Heart failure.  The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.; Reported Cause(s) of Death: HEART FAILURE
2/20/2012 1105 AM Hepatitis B vaccine (ENGERIX B GlaxoSmithKline) Lot AHBVC004AA Exp 8/23/13. 20mcg/1ml given IM deltoid - second dose in series of 3 - given at 1020AM by hospital employee health nurse. Within 45 min after injection pt. became flushed and started sweating. Fine red rash developed over arms and torso, No c/o of SOB. ZYRTEC, BENADRYL 225, Epi 0.5cc. Return visit 1925PM recurring symptoms. Throat tightness - trouble breathing. Admitted for observation.
I have pain in the neck , ears, and eye, some sound is painful, and sometime, I do not see clearly.  In the neck there some painful swollen glands. This appeared few days after the vaccination, and the pain persists.
stomach hurt really bad; other trouble with my body; trouble breathing/taking deep breath was the worst/nothing wrong with the breathing /still have trouble for taking deep breaths; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (trouble breathing/taking deep breath was the worst/nothing wrong with the breathing /still have trouble for taking deep breaths), ABDOMINAL PAIN UPPER (stomach hurt really bad) and DISCOMFORT (other trouble with my body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     The patient's past medical history included Epilepsy (patient suffered epilepsy for 14th years .) and Surgery (patient had brain surgery which stopped it from having seizures.). Concurrent medical conditions included Taste loss (almost been a year since lost the taste). Concomitant products included CLONAZEPAM for Epilepsy.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced DYSPNOEA (trouble breathing/taking deep breath was the worst/nothing wrong with the breathing /still have trouble for taking deep breaths). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (stomach hurt really bad) and DISCOMFORT (other trouble with my body). At the time of the report, DYSPNOEA (trouble breathing/taking deep breath was the worst/nothing wrong with the breathing /still have trouble for taking deep breaths), ABDOMINAL PAIN UPPER (stomach hurt really bad) and DISCOMFORT (other trouble with my body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Bone densitometry: normal (normal) normal. On an unknown date, Chest X-ray: normal (normal) was nothing wrong with the breathing and nothing was wrong with it's body. On an unknown date, Computerised tomogram: normal (normal) was nothing wrong with the breathing and nothing was wrong with it's body. On an unknown date, SARS-CoV-2 test: negative (Negative) negative and positive (Positive) tested positive for COVID  in November.. On an unknown date, Smear cervix: normal (normal) normal.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that 5 days after receiving the first dose having trouble breathing. Patient told that from time to time was running out of breath when talking and started on 19 and 20 May.  Patient reported various lab tests like chest x-ray ,pulmonary study is done on 24-Jun and computerized tomography scan. The patient also had an entire bone density test and a pap. Patient did not had any seizures but needs to take the Clonazepam which has been taking for 30 years.  Patient taking inhaler as a treatment medication.
Patient is currently being treated for Guillain Barre syndrome, with symptoms of bilateral feet weakness that then extended up to his thighs, leading to difficulty walking and falling with attempts to stand. He has had no loss of sensation and also states that he had sensation of a full bladder but could not urinate and did experience urinary incontinence.
3 days p/vax pt devel fever, swelling, pain @ site, tenderness in rt axilla, induration @ inj site;
11/9/03 Noticed numbness in feet. 11/11/03 saw MD; progressed rib cage requiring hospitalization, 11/26/03, as he could not walk. 11/26/03 spinal tap confirmed Guillain Barre (GBS). Information from Discharge summary states diarrhea. msv Information from medical records states pain in legs, back, achey, unsteady gait. msv
This spontaneous report as received from a registered nurse refers to a 6 weeks old patient. The patient was vaccinated with an expired RECOMBIVAX HB (lot number 665619/1251Y, expired date 16-JUN-2012) on 03-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
nauseas; high fever; excessive vomiting/throwing up 12 times; 10 weeks pregnant wife; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of NAUSEA (nauseas), PYREXIA (high fever), VOMITING (excessive vomiting/throwing up 12 times) and MATERNAL EXPOSURE DURING PREGNANCY (10 weeks pregnant wife) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032l20a and 011l20a) for COVID-19 vaccination.     Concurrent medical conditions included Pregnancy (Patient was pregnant with twins and it was reported that it was a high risk pregnancy.).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 22-Dec-2021, the patient experienced NAUSEA (nauseas) and PYREXIA (high fever). 22-Dec-2021, the patient experienced VOMITING (excessive vomiting/throwing up 12 times) and MATERNAL EXPOSURE DURING PREGNANCY (10 weeks pregnant wife). The patient was treated with DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 22-Dec-2021, MATERNAL EXPOSURE DURING PREGNANCY (10 weeks pregnant wife) had resolved. At the time of the report, NAUSEA (nauseas), PYREXIA (high fever) and VOMITING (excessive vomiting/throwing up 12 times) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.  Patient was pregnant with twins and it was reported that it was a high-risk pregnancy.   Diclegis did not provide relief.  Estimated due date was reported as Jul-2022.